| Financial Year |
March 31 2023 |
| Monetary Funds |
5,132,913,284.72 |
| Held-for-trading Financial Assets |
303,423,937.20 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,471,404,602.81 |
| Advances to Suppliers |
58,634,046.68 |
| Other Receivables |
54,022,337.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,163,157,038.53 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
120,703,278.69 |
| Total Current Assets |
9,560,605,627.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
77,352,924.31 |
| Investment Properties |
4,300,176.11 |
| Fixed Assetes |
16,054,921,815.73 |
| Under-construction Projects |
2,063,044,808.70 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
490,487,649.79 |
| R&D expenses |
-- |
| Goodwill |
740,879,592.80 |
| Long-Term Deferred and Prepaid Expenses |
157,364,148.57 |
| Deferred Income Tax Assets |
263,810,841.12 |
| Other Non-Current Assets |
374,824,302.44 |
| Sub-Total of Non-Current Assets |
20,907,455,156.92 |
| Total Assets |
30,468,060,784.00 |
| Short-Term Loans |
2,115,209,661.68 |
| Trading Financial liabilities |
-- |
| Notes Payable |
184,053,169.16 |
| Accounts Payable |
1,926,007,941.16 |
| Accounts Received In Advance |
46,665,024.13 |
| Employee Compensation Payable |
170,900,578.96 |
| Taxes Payable |
41,890,103.45 |
| Interest Payable |
-- |
| Dividend Payable |
1,846,836.10 |
| Other payables |
404,863,675.51 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,016,815,419.51 |
| Other Current Liabilities |
989,844.12 |
| Sub-Total of Current Liabilities |
7,036,764,073.16 |
| Long-term Loans |
3,510,929,379.58 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
16,460,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
327,373,968.71 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,468,143,786.93 |
| Total Liabilities |
11,504,907,860.09 |
| Paid-In Capital(Or Share Stock) |
3,204,484,648.00 |
| Capital Surplus |
7,135,561,772.02 |
| Surplus Reserve |
383,010,146.99 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,957,568,379.88 |
| Minority Stockholder's Interest |
3,327,385,592.69 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
15,635,767,331.22 |
| Owner's Equity（Stockholder's Equity） |
18,963,152,923.91 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
30,468,060,784.00 |
